Fact CheckerSign in

NCT04180904Completed

Diet Interventions in Psoriatic Arthritis

Source: ClinicalTrials.gov · Last updated 29 Jun 2026

Brief summary (registry, in English)

The purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).

Status (registry)
Completed
Study type
Interventional
Enrollment
92 (actual)
First submitted
14 Nov 2019
Start date
11 Mar 2021
Primary completion date
25 Nov 2024
Lead sponsor
University of Pennsylvania
NCT number
NCT04180904

What you commit to

  • Study type: Interventional
  • Participants enrolled: 92
  • From 11 Mar 2021 to the primary completion date, 25 Nov 2024
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of systemic corticosteroids

Other illness

  • All persons who would be placed at an increased risk including any medical condition that will impair the ability of the person to participate in a nutritional intervention study (e.g. insulin dependent diabetes, use of coumadin, advanced malignancy, inflammatory bowel disease, dementia)
  • History of food allergy to any of the components of olive oil or nuts

Age

  • Known pregnancy (pregnancy testing will be performed for women of childbearing age; weight changes will not accurately reflect the changes we would anticipate in pregnant patients and weight loss may be detrimental to maternal and/or fetal outcomes).

Other

  • Inability to provide informed consent
  • Plan to change systemic treatment for psoriasis or PsA in the next 4-8 weeks
  • Inability to read and write in English
  • Unwillingness to change dietary habits
  • Participation in another physical activity study and/or diet trial

Who the study is looking for

  • Age 18-80
  • Required Rheumatologist-confirmed diagnosis of PsA fulfilling Classification of Psoriatic Arthritis Criteria (CASPAR)
  • Willing to alter diet and participate for 24 weeks
  • Able to attend follow-up visits
  • Body mass index (BMI) \> 25 and \<40
  • No history of eating disorders such as anorexia or bulimia
  • Disease Activity in Psoriatic Arthritis Assessment (DAPSA) \> 10
  • Stable treatment for PsA for ≥3 months prior to enrollment (patients may be on any disease modifying anti-rheumatic drugs (DMARDs) or they can be free of systemic medications
  • Owns and uses an iPhone or Android smart phone, or is willing to use a device provided by the study team

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Women's College Hospital, University of Toronto
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.